Navigation Links
Survey: preventive mastectomy is not a regret for most women

According to a new study, most women who have a breast removed to prevent a second bout of cancer don't regret their decision.//

519 women who'd had cancer in one breast but decided to have both breasts removed in order to avoid a recurrence were surveyed. Overall, researchers found, 87 percent said they were still satisfied with their decision, as long as 23 years after the fact.

The study was led by Dr. Ann M. Geiger of Wake Forest University School of Medicine in Winston-Salem, North Carolina. The study is published in the Journal of Clinical Oncology.

Preventive mastectomy has been found to substantially lower the risk of cancer recurrence, though it won't eliminate the risk, as some breast tissue remains after surgery.

The team found that roughly three-quarters of women in both groups said they were "very" or "quite" content with their quality of life, and the large majority of those who'd had a preventive mastectomy felt good about their choice.

"It is important to remember that preventive mastectomy is a major surgical procedure likely appropriate for a very small percentage of women with breast cancer," said Dr. Ann.


'"/>




Page: 1

Related medicine news :

1. Research on causes for falling helps develop preventive strategies
2. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
3. Madras Medical College to have a Centre for preventive cardiology
4. Piercing breast led to mastectomy in teenager
5. Do not regret growing older, It is a privilege denied to many
6. Youth is a blunder; manhood a struggle; old age a regret.
7. Transdermal HRT not cardioprotective in postmenopausal women with CAD
8. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
9. Starvation in pregnant women can cause heart disease to their children
10. Brisk Walking lowers memory loss in women
11. Young womens woes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
(Date:4/26/2017)... Doylestown, Pa. (PRWEB) , ... ... ... Solutions division, which provides an agile ecosystem and domain expertise for sponsors ... end-to-end, configurable randomization and trial supply management (RTSM) software platform. Bioclinica ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... 2017 , ... Lake Park Dental is now accepting new patients with crooked ... FL. With the help of this highly-effective, yet convenient system, patients can straighten their ... and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: